CHM Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib - 24th Jun 2022, 10:04am

[annb0t]

CHM Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib
Price Sensitive: N
Date: 24th Jun 2022, 10:04am

>>> Read announcement: Google: CHM Market Announcements